Role of integrins in angiotensin II-induced proliferation of vascular smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 300, Issue 3, 2011, Pages

  Bunni, Marlene A ^a   Kramarenko, Inga I ^a   Walker, Linda ^a   Raymond, John R ^a   Garnovskaya, Maria N ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Extracellular signal regulated protein kinase 1 and 2; G protein coupled receptors; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA1 INTEGRIN; ALPHA5 INTEGRIN; ANGIOTENSIN II; ARGINYLGLYCYLASPARTIC ACID; BETA1 INTEGRIN; CD51 ANTIGEN; COLLAGEN TYPE 1; FIBRONECTIN; G PROTEIN COUPLED RECEPTOR; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUTRALIZING ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; MAMMAL CELL; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INTEGRIN ALPHA1BETA1; INTEGRIN ALPHA5BETA1; INTEGRINS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1;

MAMMALIA;

EID: 79952124628     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00179.2010     Document Type: Article

References (41)

1. Assoian RK, Klein EA. Growth control by intracellular tension and extracellular stiffness. Trends Cell Biol 18: 347-352, 2008.
2. o and induce cell migration. J Biol Chem 280: 39050-39057, 2005.
3. Berg KA, Zardeneta G, Hargreaves KM, Clarke WP, Milam SB. Integrins regulate opioid receptor signaling in trigeminal ganglion neurons. Neuroscience 144: 889-897, 2007. (Pubitemid 46013994)
4. Brassard P, Amiri F, Thibault G, Schiffrin EL. Role of angiotensin type-1 and angiotensin type-2 receptors in the expression of vascular integrins in angiotensin II-infused rats. Hypertension 47: 122-127, 2006. (Pubitemid 43177825)
5. Cabodi S, Moro L, Bergatto E, Erba E, Di Stefano P, Turco E, Tarone G, Defilippi P. Integrin regulation of epidermal growth factor (EGF) receptor and of EGF-dependent responses. Biochem Soc Trans 32: 438-442, 2004. (Pubitemid 38813532)
6. Coleman KR, Braden GA, Willingham MC, Sane DC. Vitaxin, a humanized monoclonal antibody to the vitronectin receptor (alphaVbeta3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits. Circ Res 84: 1268-1276, 1999. (Pubitemid 29270041)
7. Della Rocca GJ, Maudsley S, Daaka Y, Lefkowitz RJ, Luttrell LM. Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases. J Biol Chem 274: 13978-13984, 1999.
8. o-mediated signal transduction. J Cell Biol 153: 491-501, 2001.
9. 795 of the retinoblastoma gene product in vascular smooth muscle cells involves ERK activation. J Biol Chem 279: 24899-24905, 2004.
10. Humphries JD, Byron A, Humphries MJ. Integrin ligands at a glance. J Cell Sci 119: 3901-3903, 2006. (Pubitemid 44650863)
11. Jia N, Okamoto H, Shimizu T, Chiba S, Matsui Y, Sugawara T, Akino M, Kitabatake A. A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression. Hypertens Res 26: 737-742, 2003. (Pubitemid 37258662)
12. Juliano RL. Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. Annu Rev Pharmacol Toxicol 42: 283-323, 2002. (Pubitemid 34160528)
13. Kappert K, Schmidt G, Doerr G, Wollert-Wulf B, Fleck E, Graf K. Angiotensin II and PDGF-BB stimulate β1-integrin-mediated adhesion and spreading in human VSMCs. Hypertension 35: 255-261, 2000. (Pubitemid 30054182)
14. Kauffman R, Bean J, Zimmerman K, Brown R, Steinberg MI. Losartan, a nonpeptide Ang II receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries. Life Sci 49: PL223-PL228, 1991.
15. Kawano H, Cody RJ, Graf K, Goetze S, Kawano Y, Schnee J, Law RE, Hsueh WA. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts. Hypertension 35: 273-279, 2000. (Pubitemid 30054185)
16. 2 receptor interacts with integrin α5β1 to transactivate epidermal growth factor receptor in kidney cells. Mol Pharmacol 78: 1-9, 2010.
17. Louis H, Kakou A, Regnault V, Labat C, Bressenot A, Gao-Li J, Gardner H, Thornton SN, Challande P, Li Z, Lacolley P. Role of α1β1 in arterial stiffness and angiotensin-induced arteria wall hypertrophy in mice. Am J Physiol Heart Circ Physiol 293: H2597-H2604, 2007. (Pubitemid 47605909)
18. Marcinkiewicz C, Weinreb PH, Calvete JJ, Kisiel DG, Mousa SA, Tuszynski GP, Lobb RR. Obtustatin: a potent selective inhibitor of α1β1 integrin in vitro and angiogenesis in vivo. Cancer Res 63: 2020-2023, 2003. (Pubitemid 36538600)
19. Martinez-Lemus LA, Wu X, Wilson E, Hill MA, Davis GE, Davis MJ, Meininger GA. Integrins as unique receptors for vascular control. J Vasc Res 40: 211-233, 2003. (Pubitemid 36980724)
20. Mattila E, Pellinen T, Nevo J, Vuoriluoto K, Arjonen A, Ivaska J. Negative regulation of EGFR signaling through integrin-α1β1-mediated activation of protein tyrosine phosphatase TCPTP. Nat Cell Biol 7: 78-85, 2004. (Pubitemid 40123386)
21. Mawatari K, Liu B, Kent KC. Activation of integrin receptors is required for growth factor-induced smooth muscle cell dysfunction. J Vasc Surg 31: 375-381, 2000. (Pubitemid 30100046)
22. Miranti CK, Brugge JS. Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 4: E83-E90, 2002. (Pubitemid 34308848)
23. Moiseeva EP. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc Res 52: 372-386, 2001. (Pubitemid 33153100)
24. 1 receptor upregulation by angiotensin II and endothelin-1 in rat vascular smooth muscle cells: receptors and mechanisms. Am J Physiol Heart Circ Physiol 299: H1625-H1632, 2010.
25. Moro L, Venturino M, Bozzo C, Silengo L, Altruda F, Beguinot L, Tarone G, Defilippi P. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J 17: 6622-6632, 1998. (Pubitemid 28521796)
26. Mukhin YV, Garnovskaya MN, Ullian ME, Raymond JR. ERK is regulated by sodium-proton exchanger in rat aortic vascular smooth muscle cells. J Biol Chem 279: 1845-1852, 2004.
27. Ohtsu H, Dempsey PJ, Frank GD, Brailoiu E, Higuchi S, Suzuki H, Nakashima H, Eguchi K, Eguchi S. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II. Arterioscler Thromb Vasc Biol 26: e133-e137, 2006. (Pubitemid 44253770)
28. Okuda M, Kawahara Y, Nakayama I, Hoshijima M, Yokoyama M. Angiotensin II transduces its signal to focal adhesions via angiotensin II type I receptors in vascular smooth muscle cells. FEBS Lett 368: 343-347, 1995.
29. Otis M, Campbel S, Payet MD, Gallo-Payet N. In adrenal glomerulosa cells, angiotensin II inhibits proliferation by interfering with fibronectin-integrin signaling. Endocrinology 149: 3435-3445, 2008. (Pubitemid 351919574)
30. Plow ED, Haas TA, Zhang L, Loftus J, Smith JW. Ligand binding to integrins. J Biol Chem 275: 21785-21788, 2000. (Pubitemid 30621742)
31. Schneller M, Vuori K, Ruoslahti E. AlphaVbeta3 integrin associates with activated insulin and PDGF receptors and potentiates the biological activity of PDGF. EMBO J 16: 5600-5607, 1997. (Pubitemid 27399852)
32. Schwartz MA, Ginsberg MH. Networks and crosstalk: integrin signalling spreads. Nat Cell Biol 4: E65-E68, 2002. (Pubitemid 34308840)
33. Short SM, Boyer JL, Juliano RL. Integrins regulate the linkage between upstream and downstream events in G protein coupled receptor signaling to mitogen-activated protein kinase. J Biol Chem 275: 12970-12977, 2000. (Pubitemid 30241455)
34. Slack BE. Tyrosine phosphorylation of paxillin and focal adhesion kinase by activation of muscarinic m3 receptors is dependent on integrin engagement by the extracellular matrix. Proc Natl Acad Sci U S A 95: 7281-7286, 1998. (Pubitemid 28293243)
35. Tamura K, Okazaki M, Tamura M, Kanegae K, Okuda H, Abe H, Nakashima Y. Synergistic interaction of integrin and angiotensin II in activation of extracellular signal-regulated kinase pathways in vascular smooth muscle cells. J Cardiovasc Pharmacol 38, Suppl 1: S59-S62, 2001. (Pubitemid 33104685)
36. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639-672, 2000.
37. Ullian ME, Hutchison FN, Hazen-Martin DJ, Morinelli TA. Angiotensin II-aldosterone interactions on protein synthesis in vascular smooth muscle cells. Am J Physiol Cell Physiol 264: C1525-C1531, 1993. (Pubitemid 23198521)
38. Ullian ME, Walsh LG, Morinelli TA. Potentiation of angiotensin II action by corticosteroids in vascular tissue. Cardiovasc Res 32: 266-273, 1996. (Pubitemid 26246872)
39. 2 nucleotide receptor interaction with alphaV integrin mediates astrocyte migration. J Neurochem 95: 630-640, 2005.
40. Wu X, Mogford JE, Platts SH, Davis GE, Meininger GA, Davis MJ. Modulation of calcium current in arteriolar smooth muscle by alphaV beta3 and alpha5 beta1 integrin ligands. J Cell Biol 143: 241-252, 1998. (Pubitemid 28480532)
41. Zheng B, Clemmons DR. Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells. Proc Natl Acad Sci U S A 95: 11217-11222, 1998. (Pubitemid 28450108)